Roche

Executive Summary

Myron Holubiak, general manager of the Plymouth Group IMS subsidiary, is rejoining Roche as president of the U.S. drug business. Holubiak was in marketing, health economics and product management at Roche before going off to start his own consulting firm 13 years ago. Holubiak sold that firm, Emron, to IMS in 1994 and stayed on as a senior IMS manager. Holubiak replaces Steve Sudovar, who left the company in late October. Both Sudovar and Holubiak began their careers within Roche and subsequently formed outside consulting businesses before being recruited back to the company by Roche CEO Patrick Zenner to run the U.S. drug business